Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Search results for

There are 22,288 results that match your search.22,288 results
  • Alice appeals to Supreme Court on Section 101
    The US Supreme Court should act to bring clarity to the law on the patentability of computer-implemented inventions in the US, according to a brief filed this week
    September 06 2013
  • Lights out for Lantana
    A patent application for software that moves data between computers using email has been held to be unpatentable subject matter under Section 1(2) of the UK Patents Act, which corresponds to Article 52 of the EPC
    September 06 2013
  • How to integrate China into your global patenting strategy
    Daniel Holt, senior patent counsel at Hewlett-Packard, explains factors such as language skills may be more important than experience when selecting a patent attorney
    September 06 2013
  • shanghai-audience-400.jpg
    Injunctions under review in China
    IP owners who think their products are being infringed often want just one thing: for the infringement to stop (not patent trolls, of course, but that’s another story). In China, however, stopping infringement can be trickier than usual
    September 05 2013
  • Terry Rea
    To fight trolls, do we need more than good patents?
    There is considerable debate about devising policies to deal with patent trolls without killing innovation. Is the solution as simple as higher quality patents?
    September 04 2013
  • microsoft20logo20new.png
    Microsoft to pay €1.65 billion for Nokia patent licence
    As part of the €5.44 billion deal announced today, Microsoft will pay €1.65 billion over 10 years for a non-exclusive licence to Nokia’s portfolio of 30,000 patents
    September 03 2013
  • ipclinic-logo-300.jpg
    Good advice on a career in IP
    What’s the secret to a successful career in IP? We asked three experienced practitioners that question, but do you agree with their answers?
    September 02 2013
  • Drugs
    Mixed fortunes for pharma in China
    China is getting richer and its population is ageing. That’s a dream combination for pharmaceutical companies. But while there are plenty of opportunities for the drugs industry in the country, companies also face challenges
    September 01 2013
  • brazil-puff.jpg
    How courts in Brazil have ruled on patent prosecution
    Rafael Marques Rocha and André Ferreira de Oliveira of Daniel Advogados give an overview of court decisions covering patent prosecution in Brazil in the last decade
    Managing IP Correspondent, August 31 2013
  • fischer.jpg
    US case analysis: Myriad at the Supreme Court
    The subject of gene patentability is one of the most controversial topics in life sciences. In June 2013, the US Supreme Court reached a unanimous decision in the Association for Molecular Pathology v Myriad Genetics. It stated that companies cannot patent parts of naturally occurring human genes. Managing IP sat down with Fitzpatrick Cella Harper & Scinto attorneys Robert Fischer, John Carlin and Joshua Rothman to discuss the ruling
    Managing IP Correspondent, August 31 2013
Previous
1
...
1119
1120
1121
1122
1123
...
2228
Next